RE:A BUYOUT WOULD BE THE BEST NEWS1Buyout would be nice. But the problem is that they don't get through to the decision-makers at the big companies. The Allergan deal and the anti-aging study have unfortunately not yet made Sirona known. They need to do some real public relations work and not these ridiculous twitter posts like in the past. But that will not be possible with the current management. Since this will certainly not change, the $2 are valued much too high... unfortunately (The science is worth it, yes, but the company is not).